Stereotactic radiotherapy of the prostate: fractionation and utilization in the United States
Joseph P. Weiner, David Schwartz, Meng Shao, Virginia Osborn, Kwang Choi, David Schreiber
Radiat Oncol J. 2017;35(2):137-143.   Published online 2017 Jun 30     DOI:
Citations to this article as recorded by Crossref logo
Bowel and Bladder Reproducibility in Image Guided Radiation Therapy for Prostate Cancer: Results of a Patterns of Practice Survey
Lindsay S. Rowe, Jeremy J. Mandia, Kilian E. Salerno, Uma T. Shankavaram, Shaoli Das, Freddy E. Escorcia, Holly Ning, Deborah E. Citrin
Advances in Radiation Oncology.2022; 7(5): 100902.     CrossRef
Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer
Mark N. Alshak, Andrew Eidelberg, Susana Martinez Diaz, Michelina D. Stoddard, Silvia Formenti, Himanshu Nagar, Josephine Kang, Bilal Chughtai
World Journal of Urology.2022; 40(5): 1143.     CrossRef
Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer
Emile Gogineni, Zaker Rana, Danielle Soberman, Baho Sidiqi, Vincent D'Andrea, Lucille Lee, Louis Potters, Bhupesh Parashar
International Journal of Radiation Oncology*Biology*Physics.2021; 109(5): 1232.     CrossRef
Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response
Kyle Wang, Panayiotis Mavroidis, Trevor J. Royce, Aaron D. Falchook, Sean P. Collins, Stephen Sapareto, Nathan C. Sheets, Donald B. Fuller, Issam El Naqa, Ellen Yorke, Jimm Grimm, Andrew Jackson, Ronald C. Chen
International Journal of Radiation Oncology*Biology*Physics.2021; 110(1): 237.     CrossRef
Resident experience in brachytherapy: An analysis of Accreditation Council for Graduate Medical Education case logs for intracavitary and interstitial brachytherapy from 2007 to 2018
Ashwin Shinde, Richard Li, Arya Amini, Neha Vapiwala, Peter Orio, John A. Vargo, Catheryn Yashar, Yi-Jen Chen, Sushil Beriwal, Scott Glaser
Brachytherapy.2020; 19(6): 718.     CrossRef
Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States
Sean S. Mahase, Debra D’Angelo, Josephine Kang, Jim C. Hu, Christopher E. Barbieri, Himanshu Nagar
JAMA Network Open.2020; 3(2): e1920471.     CrossRef
A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer
Mark A. Ritter, Patrick A. Kupelian, Daniel G. Petereit, Colleen A. Lawton, Nick Anger, Heather Geye, Richard J. Chappell, Jeffrey D. Forman
Practical Radiation Oncology.2020; 10(5): 345.     CrossRef
SBRT for Localized Prostate Cancer: Is it Ready for Take-Off?
Timur Mitin, Ann Henry, Ananya Choudhury, Ronald C. Chen, Michael Pinkawa, Daniel E. Spratt
International Journal of Radiation Oncology*Biology*Physics.2019; 105(3): 618.     CrossRef
Stereotactic body radiation therapy (SBRT) for high-risk prostate cancer: Where are we now?
Alejandro Gonzalez-Motta, Mack Roach
Practical Radiation Oncology.2018; 8(3): 185.     CrossRef
Utilization of Stereotactic Radiosurgery for Renal Cell Carcinoma Brain Metastases
Waqar Haque, Vivek Verma, E.Brian Butler, Bin S. Teh
Clinical Genitourinary Cancer.2018; 16(4): e935.     CrossRef
Optimal collimator rotation based on the outline of multiple brain targets in VMAT
Jung-in Kim, Beom Seok Ahn, Chang Heon Choi, Jong Min Park, So-Yeon Park
Radiation Oncology.2018;[Epub]     CrossRef
Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes
Donald B. Fuller, Aaron D. Falchook, Tami Crabtree, Brent L. Kane, Clinton A. Medbery, Kelly Underhill, James R. Gray, Anuj Peddada, Ronald C. Chen
European Urology Oncology.2018; 1(6): 540.     CrossRef